<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04792918</url>
  </required_header>
  <id_info>
    <org_study_id>NEC</org_study_id>
    <nct_id>NCT04792918</nct_id>
  </id_info>
  <brief_title>Characterization of Intestinal Microbiota Stability in Preterm Born Neonates</brief_title>
  <acronym>NEC</acronym>
  <official_title>Intestinal Microbiome Strain-level Stability in NEC/ or LOS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emma Marie Caroline Slack</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ETH Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study around very-low birthweight preterm infants at high risk of developing necrotizing&#xD;
      enterocolitis (NEC) or late-onset sepsis (LOS). Collection of stool and other biological&#xD;
      samples to assess the strain-level stability of gastrointestinal microbiota in these preterm&#xD;
      infants who may or may not develop NEC/LOS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to collect biological samples (stool, stomach fluid, urine, and blood) from&#xD;
      preterm infants at risk of developing NEC or LOS; as well as environmental samples from&#xD;
      infants' hospital surroundings (swabs, air), nutritional intake (formula, breastmilk) and&#xD;
      samples from their family members (faeces, vaginal swab).&#xD;
&#xD;
      The main focus of the study is to assess strain-level stability of gastrointestinal&#xD;
      microbiota in these infants and potentially assess the source of disease-causing microbiota&#xD;
      species/strains.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2021</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>Strain-level stability</measure>
    <time_frame>24 months</time_frame>
    <description>Identify members of the gastrointestinal microbiota (species/strains) that are associated with development of NEC or LOS in very-low birthweight/very preterm Identify members of the gastrointestinal microbiota (species/strains) that are associated with development of NEC or LOS in very-low birthweight/very preterm infants via changes in frequencies, absolute colonization levels, or temporal stability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Source of bacterial species/strains</measure>
    <time_frame>24 months</time_frame>
    <description>Quantify genetic similarity between potentially disease-causing microbiota strains found within NEC/LOS patients and within family members (faeces, breastmilk, vaginal swab) and hospital surroundings</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Necrotising Enterocolitis</condition>
  <condition>Late-Onset Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>NEC/LOS preterm infants</arm_group_label>
    <description>Collection of biological samples (stool, stomach fluid, blood, urine) and health-related data over the first few weeks of life, additional stool samples after onset of NEC/LOS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm infants not developing NEC/LOS</arm_group_label>
    <description>Collection of biological samples (stool, stomach fluid, blood, urine) and health-related data over the first few weeks of life</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Family members of preterm infants</arm_group_label>
    <description>Collection of biological samples (stool, breastmilk, vaginal swab) and health-related data at one timepoint after the birth of the preterm infant from members of the family (mother, father)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is represented by infants born at gestational age below 32 weeks (very&#xD;
        preterm born infants) or with a birthweight below 1500g (very low birthweight infants). It&#xD;
        is estimated that approximately 100 infants will be enrolled during the study period. As&#xD;
        the aim is to study stability of the premature microbiota within individual patients, the&#xD;
        study design precludes the need of control groups.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -Preterm infants with a gestational age &lt; 32 weeks or a birthweight &lt; 1500g and their&#xD;
        family members&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intestinal atresia&#xD;
&#xD;
          -  Live born infants referred to from other hospitals later than 3 days after birth&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emma Slack, Prof Dr</last_name>
    <phone>+41 44 632 45 91</phone>
    <email>emma.slack@hest.ethz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Noemi Meier, Dr</last_name>
    <email>noemeier@ethz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Children's Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Trück, PD Dr med</last_name>
      <phone>+41 44 266 83 94</phone>
      <email>johannes.trueck@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Johannes Trück, PD Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giancarlo Natalucci, Prof Dr med</last_name>
      <phone>+41 44 255 53 86</phone>
      <email>giancarlo.natalucci@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Giancarlo Natalucci, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2021</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>ETH Zurich</investigator_affiliation>
    <investigator_full_name>Emma Marie Caroline Slack</investigator_full_name>
    <investigator_title>Prof Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Sepsis</mesh_term>
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

